Fas ligand-mediated killing by intestinal intraepithelial lymphocytes : Participation in intestinal graft-versus-host disease
| dc.contributor.author | Lin, Tesu | deu |
| dc.contributor.author | Brunner, Thomas | |
| dc.contributor.author | Tietz, Brian | deu |
| dc.contributor.author | Madsen, Jill | deu |
| dc.contributor.author | Bonfoco, Emanuela | deu |
| dc.contributor.author | Reaves, Miriam | deu |
| dc.contributor.author | Huflejt, Margaret | deu |
| dc.contributor.author | Green, Douglas R. | deu |
| dc.date.accessioned | 2011-07-29T08:30:11Z | deu |
| dc.date.available | 2011-07-29T08:30:11Z | deu |
| dc.date.issued | 1998 | deu |
| dc.description.abstract | In vitro studies have demonstrated that intestinal intraepithelial lymphocytes (IEL) are constitutively cytotoxic; however, the mechanism and target of their cytotoxicity are unknown. Apoptosis of intestinal epithelial cells (IEC) and an increase in IEL numbers are classical signs of intestinal graft-versus-host disease (GVHD), although whether IEL can mediate IEC apoptosis directly in GVHD is unclear. Recent evidence suggests that target epithelial organ injury observed in GVHD is predominantly Fas-mediated; therefore, we investigated the possibility that IEL induce apoptosis of IEC through a Fas-mediated mechanism. Here, we demonstrate that the IEL isolated from normal mice readily display potent Fas ligand (FasL)-mediated killing activity after CD3 stimulation, and that IEC express Fas, suggesting that IEC are potential targets for FasL-mediated killing by IEL. In vitro, IEL isolated from GVHD mice have markedly increased FasL-mediated killing potential and are spontaneously cytolytic toward host-derived tumor cells predominantly through a Fas-mediated pathway. In vivo transfer of IEL isolated from GVHD mice induced significantly more IEC apoptosis in F1 wild-type mice than in Fas-defective F1lpr mice. Thus, these results demonstrate that FasL-mediated death of IEC by IEL is a major mechanism of IEC apoptosis seen in GVHD. | |
| dc.description.version | published | |
| dc.identifier.citation | First publ. in: The journal of clinical investigation : JCI ; 101 (1998), 3. - S. 570-577 | deu |
| dc.identifier.doi | 10.1172/JCI896 | |
| dc.identifier.pmid | 9449689 | |
| dc.identifier.ppn | 352885696 | deu |
| dc.identifier.uri | http://kops.uni-konstanz.de/handle/123456789/14307 | |
| dc.language.iso | eng | deu |
| dc.legacy.dateIssued | 2011-07-29 | deu |
| dc.rights | terms-of-use | deu |
| dc.rights.uri | https://rightsstatements.org/page/InC/1.0/ | deu |
| dc.subject.ddc | 570 | deu |
| dc.title | Fas ligand-mediated killing by intestinal intraepithelial lymphocytes : Participation in intestinal graft-versus-host disease | eng |
| dc.type | JOURNAL_ARTICLE | deu |
| dspace.entity.type | Publication | |
| kops.citation.bibtex | @article{Lin1998ligan-14307,
year={1998},
doi={10.1172/JCI896},
title={Fas ligand-mediated killing by intestinal intraepithelial lymphocytes : Participation in intestinal graft-versus-host disease},
number={3},
volume={101},
issn={0021-9738},
journal={The journal of clinical investigation : JCI},
pages={570--577},
author={Lin, Tesu and Brunner, Thomas and Tietz, Brian and Madsen, Jill and Bonfoco, Emanuela and Reaves, Miriam and Huflejt, Margaret and Green, Douglas R.}
} | |
| kops.citation.iso690 | LIN, Tesu, Thomas BRUNNER, Brian TIETZ, Jill MADSEN, Emanuela BONFOCO, Miriam REAVES, Margaret HUFLEJT, Douglas R. GREEN, 1998. Fas ligand-mediated killing by intestinal intraepithelial lymphocytes : Participation in intestinal graft-versus-host disease. In: The journal of clinical investigation : JCI. 1998, 101(3), pp. 570-577. ISSN 0021-9738. Available under: doi: 10.1172/JCI896 | deu |
| kops.citation.iso690 | LIN, Tesu, Thomas BRUNNER, Brian TIETZ, Jill MADSEN, Emanuela BONFOCO, Miriam REAVES, Margaret HUFLEJT, Douglas R. GREEN, 1998. Fas ligand-mediated killing by intestinal intraepithelial lymphocytes : Participation in intestinal graft-versus-host disease. In: The journal of clinical investigation : JCI. 1998, 101(3), pp. 570-577. ISSN 0021-9738. Available under: doi: 10.1172/JCI896 | eng |
| kops.citation.rdf | <rdf:RDF
xmlns:dcterms="http://purl.org/dc/terms/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
xmlns:bibo="http://purl.org/ontology/bibo/"
xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
xmlns:foaf="http://xmlns.com/foaf/0.1/"
xmlns:void="http://rdfs.org/ns/void#"
xmlns:xsd="http://www.w3.org/2001/XMLSchema#" >
<rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/14307">
<dc:creator>Brunner, Thomas</dc:creator>
<dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
<dc:contributor>Brunner, Thomas</dc:contributor>
<dcterms:title>Fas ligand-mediated killing by intestinal intraepithelial lymphocytes : Participation in intestinal graft-versus-host disease</dcterms:title>
<dc:contributor>Tietz, Brian</dc:contributor>
<dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/14307/2/1998_Lin_Fas%20Ligand%20med%20kill.pdf"/>
<dc:creator>Huflejt, Margaret</dc:creator>
<dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-07-29T08:30:11Z</dcterms:available>
<dcterms:issued>1998</dcterms:issued>
<dc:language>eng</dc:language>
<dc:contributor>Lin, Tesu</dc:contributor>
<foaf:homepage rdf:resource="http://localhost:8080/"/>
<dc:creator>Bonfoco, Emanuela</dc:creator>
<dc:rights>terms-of-use</dc:rights>
<dcterms:bibliographicCitation>First publ. in: The journal of clinical investigation : JCI ; 101 (1998), 3. - S. 570-577</dcterms:bibliographicCitation>
<dc:contributor>Madsen, Jill</dc:contributor>
<dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
<dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-07-29T08:30:11Z</dc:date>
<dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/14307/2/1998_Lin_Fas%20Ligand%20med%20kill.pdf"/>
<dc:creator>Tietz, Brian</dc:creator>
<dc:creator>Reaves, Miriam</dc:creator>
<dc:creator>Madsen, Jill</dc:creator>
<dc:contributor>Huflejt, Margaret</dc:contributor>
<dc:contributor>Reaves, Miriam</dc:contributor>
<dcterms:abstract>In vitro studies have demonstrated that intestinal intraepithelial lymphocytes (IEL) are constitutively cytotoxic; however, the mechanism and target of their cytotoxicity are unknown. Apoptosis of intestinal epithelial cells (IEC) and an increase in IEL numbers are classical signs of intestinal graft-versus-host disease (GVHD), although whether IEL can mediate IEC apoptosis directly in GVHD is unclear. Recent evidence suggests that target epithelial organ injury observed in GVHD is predominantly Fas-mediated; therefore, we investigated the possibility that IEL induce apoptosis of IEC through a Fas-mediated mechanism. Here, we demonstrate that the IEL isolated from normal mice readily display potent Fas ligand (FasL)-mediated killing activity after CD3 stimulation, and that IEC express Fas, suggesting that IEC are potential targets for FasL-mediated killing by IEL. In vitro, IEL isolated from GVHD mice have markedly increased FasL-mediated killing potential and are spontaneously cytolytic toward host-derived tumor cells predominantly through a Fas-mediated pathway. In vivo transfer of IEL isolated from GVHD mice induced significantly more IEC apoptosis in F1 wild-type mice than in Fas-defective F1lpr mice. Thus, these results demonstrate that FasL-mediated death of IEC by IEL is a major mechanism of IEC apoptosis seen in GVHD.</dcterms:abstract>
<void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
<dc:creator>Green, Douglas R.</dc:creator>
<dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
<bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/14307"/>
<dc:contributor>Bonfoco, Emanuela</dc:contributor>
<dc:creator>Lin, Tesu</dc:creator>
<dc:contributor>Green, Douglas R.</dc:contributor>
</rdf:Description>
</rdf:RDF> | |
| kops.description.openAccess | openaccessgreen | |
| kops.flag.knbibliography | false | |
| kops.identifier.nbn | urn:nbn:de:bsz:352-143078 | deu |
| kops.sourcefield | The journal of clinical investigation : JCI. 1998, <b>101</b>(3), pp. 570-577. ISSN 0021-9738. Available under: doi: 10.1172/JCI896 | deu |
| kops.sourcefield.plain | The journal of clinical investigation : JCI. 1998, 101(3), pp. 570-577. ISSN 0021-9738. Available under: doi: 10.1172/JCI896 | deu |
| kops.sourcefield.plain | The journal of clinical investigation : JCI. 1998, 101(3), pp. 570-577. ISSN 0021-9738. Available under: doi: 10.1172/JCI896 | eng |
| kops.submitter.email | regine.winter@uni-konstanz.de | deu |
| relation.isAuthorOfPublication | f61b843f-0378-4683-b89b-70ad6aec10ea | |
| relation.isAuthorOfPublication.latestForDiscovery | f61b843f-0378-4683-b89b-70ad6aec10ea | |
| source.bibliographicInfo.fromPage | 570 | |
| source.bibliographicInfo.issue | 3 | |
| source.bibliographicInfo.toPage | 577 | |
| source.bibliographicInfo.volume | 101 | |
| source.identifier.issn | 0021-9738 | |
| source.periodicalTitle | The journal of clinical investigation : JCI |
Dateien
Originalbündel
1 - 1 von 1
Vorschaubild nicht verfügbar
- Name:
- 1998_Lin_Fas Ligand med kill.pdf
- Größe:
- 549.46 KB
- Format:
- Adobe Portable Document Format
Lizenzbündel
1 - 1 von 1
Vorschaubild nicht verfügbar
- Name:
- license.txt
- Größe:
- 1.92 KB
- Format:
- Plain Text
- Beschreibung:

